메뉴 건너뛰기




Volumn 6, Issue 10, 2006, Pages 1101-1110

Small molecule inhibitors of protein kinases in cancer - How to overcome resistance

Author keywords

Active kinase conformation; Anti cancer agents; Drug design; Inactive kinase conformation; Protein kinase inhibitors; Selectivity

Indexed keywords

2,4 DIMETHYL 5 (2 OXO 1H INDOL 3 YLMETHYLENE) 3 PYRROLEPROPIONIC ACID; 4 [6 METHOXY 7 [3 (1 PIPERIDINYL)PROPOXY] 4 QUINAZOLINYL] 1 PIPERAZINECARBOXYLIC ACID (4 ISOPROPOXYPHENYL)AMIDE; 6 (2,6 DICHLOROPHENYL) 8 METHYL 2 (3 METHYLTHIOANILINO) 8H PYRIDO[2,3 D]PYRIMIDIN 7 ONE; 7 HYDROXYSTAUROSPORINE; ABELSON KINASE; ANTINEOPLASTIC AGENT; CANERTINIB; ERBSTATIN; ERLOTINIB; GEFITINIB; IMATINIB; LAPATINIB; MIDOSTAURIN; NILOTINIB; OXINDOLE; PELITINIB; PHTHALAZINE DERIVATIVE; PROTEIN KINASE INHIBITOR; PROTEIN TYROSINE KINASE; QUINAZOLINE DERIVATIVE; RUBOXISTAURIN; SEMAXANIB; STAUROSPORINE DERIVATIVE; SU 4948; SUNITINIB; TYRPHOSTIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VANDETANIB; VASCULOTROPIN; VATALANIB;

EID: 33749507015     PISSN: 13895575     EISSN: None     Source Type: Journal    
DOI: 10.2174/138955706778560184     Document Type: Review
Times cited : (15)

References (76)
  • 13


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.